Source link : https://www.newshealth.biz/health-news/novel-anti-igg-drug-hits-mark-in-sjogrens-patients/
WASHINGTON — A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren’s syndrome, a researcher reported here. Patients receiving the infusion drug, called nipocalimab, at 15 mg/kg every 2 weeks showed significantly greater improvement in a modified version of the EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI) after […]
Author : News Health
Publish date : 2024-11-19 15:37:32
Copyright for syndicated content belongs to the linked Source.
inHealth